# Psilocybin Therapy for Depression in Parkinson's Disease

> **NCT06455293** · PHASE2 · RECRUITING · sponsor: **Joshua Woolley, MD, PhD** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson Disease
- Depression

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT06455293
- **Lead sponsor:** Joshua Woolley, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-19
- **Primary completion:** 2027-06
- **Final completion:** 2028-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06455293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06455293, "Psilocybin Therapy for Depression in Parkinson's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06455293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*